MyFinsight
Home
Blog
About
Contact
Download
Download image
Metabolic
$237,558K
Oncology
$201,239K
Other
$93,318K
Central Nervous System
$80,207K
Cardiology
$56,261K
Antiviral And Anti
Infective
$38,021K
Revenue, net (includes
7.3 million and 13.8...
$706,604K
Interest income, net
$5,117K
(-20.83%↓ Y/Y)
Miscellaneous income
(expense), net
$971K
(153.47%↑ Y/Y)
Income from operations
$141,503K
(24.65%↑ Y/Y)
Total other income,
net
$6,088K
(31.01%↑ Y/Y)
Total operating
expenses
$565,101K
Income before income
taxes
$147,591K
(24.90%↑ Y/Y)
Total direct costs
$510,278K
Selling, general and
administrative
$47,917K
Depreciation
$6,751K
Amortization
$155K
Net income
$123,870K
(8.09%↑ Y/Y)
Income tax provision
$23,721K
(563.52%↑ Y/Y)
Reimbursable Out Of Pocket
Costs
$312,004K
Direct Costs
$198,274K
Back
Back
Income Statement
source: myfinsight.com
Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. (MEDP)